Evaluation of Immunomodulatory and Hematologic Cell Outcome in Heroin/Opioid Addicts
Table 2
Inflammatory series and platelet parameters of both groups.
Laboratory parameters
Statistic+
HG (n=51)
CG (n=50)
p-value
Platelet (PLT, K/uL)
Mean ± Sd
263.73±72.22
233.90±54.30
92.80
0.010
Mean Platelet Volume (MPV, fl)
Med ± IR
6.77±1.08
8.72±2.10
79.44
≤0.001#
Plateletcrit (PCT, GSD)
Mean ± Sd
0.19±0.05
0.20±0.04
93.18
0.154
Platelet Distribution Width (PDW, %)
Med ± IR
17.20±1.00
16.90±5.27
57.79
0.144
White Blood Cell Count (WBC, K/uL)
Med ± IR
8.55±3.59
7.50±1.68
75.48
0.001#
Neutrophils (NEUn, K/uL)
Med ± IR
5.52±2.89
4.19±1.35
79.57
≤0.001#
Neutrophil (NEU%, K/uL)
Mean ± Sd
63.50±7.60
56.47±7.56
98.97
≤0.001#
Lymphocytes (LYMn, K/uL)
Mean ± Sd
2.51±0.96
2.60±0.65
88.09
0.558
Lymphocyte (LYM%, K/uL)
Mean ± Sd
27.22±7.16
34.88±7.09
98.98
≤0.001#
Monocytes (MONOn, K/uL)
Med ± IR
0.50±0.33
0.50±0.18
81.14
0.311
Monocytes (MONO %, K/uL)
Mean ± Sd
6.18±1.76
6.35±1.74
98.98
0.624
Eosinophils (EOSn, K/uL)
Med ± IR
0.19±0.19
0.16±0.10
72.75
0.250
Eosinophils (EOS%, K/uL)
Med ± IR
2.11±1.81
1.88±1.33
86.38
0.696
Basophils (BASOn, K/uL)
Mean ± Sd
0.067±0.06
0.068±0.06
55.16
0.550
Basophils (BASO%, K/uL)
Mean ± Sd
0.77±0.34
0.84±0.47
89.12
0.421
Platelet / lymphocyte ratio (PLR)
Med ± IR
107.88±80.31
91.16±32.67
81.82
0.014
Neutrophil / lymphocyte ratio (NLR)
Med ± IR
2.31±1.42
1.61±0.95
78.36
≤0.001#
Significant at the 0.05 level (two-tailed). at the 0.001 level (two-tailed). Division (Mean ± SD) for parametric analysis and Median ± Interquartile (Med ± IR) range for nonparametric analysis. -correction to the degrees of freedom (df).
